Canaccord Genuity Cuts Price Target on Teva (TEVA)
Tweet
Share
E-mailGet Alerts TEVA Hot Sheet
Price: $35.01 --0%
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 14 | New: 20
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 14 | New: 20
Join SI Premium – FREE
Canaccord Genuity maintained a Buy rating on Teva Pharma (NASDAQ: TEVA) and cut its price target to $50.00 (from $52.00).
"We still think 2013 will mark a better year for the stock but outperformance is unlikely until after the Dec. 11 strategy meeting. P&L visibility is low into the meeting but if properly messaged against a lower 2013 hurdle we could see a reset to a stock that's been out of favor for over a year," said analyst Randall Stanicky.
Canaccord Genuity lowered EPS estimates heading into Q3, and it also sees lower EPS through 2013-15 due to lower U.S. generics sales.
For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.
Shares of Teva Pharma closed at $38.10 yesterday.
"We still think 2013 will mark a better year for the stock but outperformance is unlikely until after the Dec. 11 strategy meeting. P&L visibility is low into the meeting but if properly messaged against a lower 2013 hurdle we could see a reset to a stock that's been out of favor for over a year," said analyst Randall Stanicky.
Canaccord Genuity lowered EPS estimates heading into Q3, and it also sees lower EPS through 2013-15 due to lower U.S. generics sales.
For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.
Shares of Teva Pharma closed at $38.10 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Berenberg Upgrades Mersen SA (MRN:FP) to Buy
- Raymond James Downgrades CIGNA (CI) to Outperform
- Guardant Health (GH) PT Raised to $180 at Stifel on Clean Beat and Raise Q2
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
